DR. REDDY'S LABORATORIES
Sector : Pharmaceuticals and health care | Largecap | BSE
Here's the live share price of Dr. Reddy's Laboratories along with daily highs, lows, percentage changes and volume trends, and, all financial information.
-1.47₹ -18.65
As on Jan 1, 2026, 4:01 PM IST
Dr. Reddy's Laboratories Price Performance
Today's LowToday's High
₹1,249.00₹1,266.40
₹1,252.40
52 Weeks' Low52 Weeks' High
₹1,025.90₹1,404.60
₹1,252.40
Open Price
₹1,266.20
Prev. Close
₹1,271.05
Volume
20,693
Over the last 5 years, the share price of Dr. Reddy's Laboratories has gained 3.63% CAGR. Over the past year, the corresponding return has been -8.55%.
Dr. Reddy's Laboratories’s current P/E of 18.11x helps give context to how the market is valuing the stock based on recent earnings and growth expectations.
Dr. Reddy's Laboratories Peer Comparision
Name | 1W(%) | 1M(%) | 3M(%) | 6M(%) | 1Y(%) | 3Y(%) | 5Y(%) |
|---|---|---|---|---|---|---|---|
| Dr. Reddy's Laboratories | -1.10 | -0.60 | 0.49 | -1.92 | -8.55 | 13.90 | 3.63 |
| Sun Pharmaceutical Industries | -0.62 | -4.48 | 5.54 | 3.57 | -8.63 | 20.09 | 23.70 |
| Divi's Laboratories | -2.36 | -1.25 | 11.06 | -7.42 | 4.47 | 23.42 | 10.52 |
| Torrent Pharmaceuticals | 0.38 | 3.02 | 8.01 | 12.66 | 12.67 | 35.45 | 22.46 |
| Cipla | 0.24 | -1.56 | -0.91 | -1.05 | -2.02 | 11.89 | 12.66 |
| Lupin | -0.14 | 0.94 | 6.27 | 7.38 | -10.95 | 42.18 | 16.05 |
| Zydus Lifesciences | -0.32 | -2.33 | -7.78 | -8.68 | -6.07 | 29.66 | 13.83 |
| Mankind Pharma | -1.42 | -3.00 | -11.30 | -5.49 | -25.09 | 14.95 | 8.72 |
| Aurobindo Pharma | -1.38 | -1.59 | 10.01 | 5.60 | -11.51 | 40.13 | 5.21 |
| Alkem Laboratories | -1.87 | -2.59 | 0 | 12.53 | -2.04 | 22.11 | 13.10 |
| Abbott India | -0.45 | -4.47 | -4.64 | -17.90 | -5.09 | 9.96 | 12.58 |
| Laurus Labs | 2.33 | 7.89 | 27.30 | 48.81 | 80.49 | 43.79 | 25.73 |
| Glenmark Pharmaceuticals | 0.44 | 4.54 | 3.56 | 15.62 | 25.67 | 68.08 | 32.18 |
| Biocon | -2.59 | -1.71 | 11.90 | 7.01 | 5.14 | 13.76 | -3.59 |
| GlaxoSmithKline Pharmaceuticals | -1.19 | -1.58 | -8.88 | -26.74 | 9.89 | 23.07 | 8.79 |
| Ajanta Pharma | 7.07 | 14.67 | 22.42 | 17.20 | -2.20 | 34.55 | 21.67 |
| Anthem Biosciences | -4.37 | -3.13 | -17.20 | -12.51 | -12.51 | -4.36 | -2.64 |
| Ipca Laboratories | -1.19 | -1.73 | 5.20 | 1.81 | -17.68 | 18.64 | 5.08 |
| J B Chemicals & Pharmaceuticals | 0.03 | 2.63 | 7.46 | 10.22 | -3.34 | 22.56 | 28.55 |
| Gland Pharma | 4.16 | -0.48 | -13.26 | -8.46 | -5.07 | 2.89 | -6.25 |
Over the last one year, Dr. Reddy's Laboratories has declined 8.55% compared to peers like Sun Pharmaceutical Industries (-8.63%), Divi's Laboratories (4.47%), Torrent Pharmaceuticals (12.67%). From a 5 year perspective, Dr. Reddy's Laboratories has underperformed peers relative to Sun Pharmaceutical Industries (23.70%) and Divi's Laboratories (10.52%).
Dr. Reddy's Laboratories Financials
Dr. Reddy's Laboratories Stock Technicals
Moving Average
| Day | SMA | EMA |
|---|---|---|
| 5 | 1,270.59 | 1,270.28 |
| 10 | 1,274.63 | 1,271.42 |
| 20 | 1,272.63 | 1,268.82 |
| 50 | 1,254.13 | 1,261.74 |
| 100 | 1,258.23 | 1,258.53 |
| 200 | 1,243.38 | 1,254.13 |
Dr. Reddy's Laboratories Share Holding Pattern
In the latest quarter, Dr. Reddy's Laboratories remained same as its previous close in promoter holding, while DII stake increased to 38.82%, FII holding fell to 24.69%, and public shareholding moved down to 9.62% compared to the previous quarter — reflecting a shift in investor sentiment across categories.
Dr. Reddy's Laboratories Stock Mutual Fund Holdings
Fund Name | No. Of Shares | % of AUM | Amount Invested(in ₹ crore) |
|---|---|---|---|
| 1,31,25,545 | 1.27 | 1,652.24 | |
| 1,18,45,856 | 2.47 | 1,491.16 | |
| 53,57,429 | 1.34 | 674.39 | |
| 50,36,728 | 9.81 | 634.02 | |
| 39,16,074 | 5.83 | 492.96 | |
| 36,55,647 | 0.59 | 460.17 | |
| 33,93,201 | 0.98 | 427.14 | |
| 31,77,174 | 0.57 | 399.94 | |
| 29,09,812 | 0.49 | 366.29 | |
| 24,38,116 | 0.73 | 306.91 |
* Excluding Index & Arbitrage Funds
Dr. Reddy's Laboratories Futures
| Price | (%) As on Invalid Date IST |
| Open Interest | (%) |
| High | |
| Low | |
| Open | |
| Close | |
| Contract Traded | |
| Turnover (in lakhs) |
Dr. Reddy's Laboratories Options
Dr. Reddy's Laboratories Corporate Actions
Date Time | Announcement |
|---|---|
| Jan 01, 2026, 1:24 AM IST | Dr. Reddy's Labs - Disclosure Under Regulation 30 Of SEBI (LODR) Regulations, 2015 |
| Dec 23, 2025, 9:56 PM IST | Dr. Reddy's Labs - Board Meeting Intimation for Approval Of The Unaudited Standalone And Consolidated Financial Results Of Th |
| Dec 16, 2025, 8:16 PM IST | Dr. Reddy's Labs - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation |
| Dec 13, 2025, 2:58 AM IST | Dr. Reddy's Labs - Disclosure Under Regulation 30 Of SEBI (LODR) Regulations, 2015 |
| Dec 12, 2025, 10:10 PM IST | Dr. Reddy's Labs - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation |
About Dr. Reddy's Laboratories
Dr. Reddy's Laboratories Ltd. is a Public Limited Listed company incorporated on 24/02/1984 and has its registered office in the State of Telangana, India. Company's Corporate Identification Number(CIN) is L85195TG1984PLC004507 and registration number is 004507. Currently Company is involved in the business activities of Manufacture of other pharmaceutical and botanical products like hina powder etc.. Company's Total Operating Revenue is Rs. 23115.40 Cr. and Equity Capital is Rs. 83.40 Cr. for the Year ended 31/03/2025.
- IndustryPharmaceuticals
- Address8-2-337, Road No. 3, Hyderabad Telangana 500034
- Contact
Management
- Mr. K Satish ReddyChairman
- Mr. G V PrasadCo-Chairman & Manag. Director
- Dr. Claudio AlbrechtIndependent Director
- Mr. Leo PuriIndependent Director
- Ms. Shikha SharmaIndependent Director
- Mr. Sanjiv MehtaIndependent Director
- Mr. Arun M KumarIndependent Director
- Dr. K P KrishnanIndependent Director
- Ms. Penny WanIndependent Director
- Dr. Alpna SethIndependent Director
FAQs on Dr. Reddy's Laboratories Share Price
What is the share price of Dr. Reddy's Laboratories?
The share price of any company is dynamic and keeps changing depending on the trade initiated. The shares have a fixed opening rate and closing rate. The share price for Dr. Reddy's Laboratories is ₹1,252.40 as on Jan 01, 2026.
What kind of stock is Dr. Reddy's Laboratories?
The Dr. Reddy's Laboratories is operating in the Pharmaceuticals and health care Sector. It is classified as a Largecap stock on the BSE.
What is the Market Cap of Dr. Reddy's Laboratories?
The market cap of Dr. Reddy's Laboratories is ₹104,529.11 Cr as on Jan 01, 2026.
What are today's High and Low prices of Dr. Reddy's Laboratories?
Today’s highest and lowest price of Dr. Reddy's Laboratories are ₹1,266.40 and ₹1,249.00.
What are the 52 Week High and 52 Week Low of Dr. Reddy's Laboratories?
The 52-week high/low is the highest and lowest price at which Dr. Reddy's Laboratories stock has traded in the past 52-week or nearly a year. The 52-week high of Dr. Reddy's Laboratories is ₹1,404.60 and 52-week low of Dr. Reddy's Laboratories is ₹1,025.90 as on Jan 01, 2026.
How has the Dr. Reddy's Laboratories performed historically in terms of returns?
The Dr. Reddy's Laboratories has shown returns of -1.47% over the past day, -0.6% for the past month, 0.49% over 3 months, -8.55% over 1 year, 13.9% across 3 years, and 3.63% over 5 years.
What are the P/E ratio, dividend yield and PB ratio of Dr. Reddy's Laboratories?
P/E ratio of and PB ratio of Dr. Reddy's Laboratories are 18.11 and 2.90 on Jan 01, 2026. While the company gives a dividend yield of 0.64 per annum.
✕
Market Pulse